# Kedplasma LLC – FDA Inspection, Sep 16, 2026

Source: https://www.keypedia.com/records/fda_inspections/kedplasma-llc/718ba1ea-950b-4669-8097-2d0d9b07eb35
Source feed: FDA_Inspections

> FDA inspection 1292706 of Kedplasma LLC, September 16, 2026. 1 citation under 21 CFR part 606. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1292706
- Company Name: Kedplasma LLC
- Inspection Date: 2026-09-16
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1106115 - 2019-08-27
- FDA Inspection 963528 - 2016-02-23
- FDA Inspection 847659 - 2013-09-11
- FDA Inspection 706414 - 2011-03-15

## Related Officers

- [FDA Personnel](https://www.keypedia.com/people/deepa-e-vadakkan/89c0e1c7-4f9e-4668-81a8-e5a9ab6a0e34)

Company: https://www.keypedia.com/companies/kedplasma-llc/1ab01add-0d45-4eee-8a63-c87cc6d1fb01

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9